Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico.
Roman-Montes CM, Bojorges-Aguilar S, Corral-Herrera EA, Rangel-Cordero A, Díaz-Lomelí P, Cervantes-Sanchez A, Martinez-Guerra BA, Rajme-López S, Tamez-Torres KM, Martínez-Gamboa RA, González-Lara MF, Ponce-de-Leon A, Sifuentes-Osornio J. Roman-Montes CM, et al. J Fungi (Basel). 2023 May 18;9(5):583. doi: 10.3390/jof9050583. J Fungi (Basel). 2023. PMID: 37233294 Free PMC article.
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic.
Martinez-Guerra BA, Gonzalez-Lara MF, de-Leon-Cividanes NA, Tamez-Torres KM, Roman-Montes CM, Rajme-Lopez S, Villalobos-Zapata GI, Lopez-Garcia NI, Martínez-Gamboa A, Sifuentes-Osornio J, Ortiz-Brizuela E, Ochoa-Hein E, Galindo-Fraga A, Bobadilla-Del-Valle M, Ponce-de-León A. Martinez-Guerra BA, et al. Antibiotics (Basel). 2021 Feb 11;10(2):182. doi: 10.3390/antibiotics10020182. Antibiotics (Basel). 2021. PMID: 33670316 Free PMC article.
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY.
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, Pérez-García E, Olivas-Martínez A, Rajme-López S, Martinez-Guerra BA, de-León-Cividanes NA, Fernández-García OA, Guerrero-Torres L, Torres-González L, Carrera-Patiño FA, Corral-Herrera EA, Hernández-Alemón AN, Tovar-Vargas MLÁ, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz ÓA, Cárdenas-Fragoso JL, Vidal-Mayo JJ, Hernández-Gilsoul T, Rivero-Sigarroa E, Domínguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-González V, Calva-Mercado JJ, Sierra-Madero JG, López-Íñiguez Á, Ochoa-Hein E, Crabtree-Ramírez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gulías-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-León A. Ortiz-Brizuela E, et al. Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211. Rev Invest Clin. 2020. PMID: 32584326
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY.
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, Pérez-García E, Olivas-Martínez A, Rajme-López S, Martinez-Guerra BA, de-León-Cividanes NA, Fernández-García OA, Guerrero-Torres L, Torres-González L, Carrera-Patiño FA, Corral-Herrera EA, Hernández-Alemón AN, Tovar-Vargas MLÁ, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz ÓA, Cárdenas JL, Vidal-Mayo JJ, Hernández-Gilsoul T, Rivero-Sigarroa E, Domínguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-González V, Calva-Mercado JJ, Sierra-Madero JG, López-Íñiguez Á, Ochoa-Hein E, Crabtree-Ramírez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gulías-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-León A. Ortiz-Brizuela E, et al. Rev Invest Clin. 2020;72(4):252-258. doi: 10.24875/RIC.20000334. Rev Invest Clin. 2020. PMID: 33064701 Free article. No abstract available.
In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.
Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, Medrano-Borromeo C, Martínez-Valenzuela A, Román-Montes CM, Martínez-Guerra B, González-Lara MF, Hernandez-Gilsoul T, Herrero AG, Tamez-Flores KM, Ochoa-Hein E, Ponce-de-León A, Galindo-Fraga A, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J. Olivas-Martínez A, et al. PLoS One. 2021 Feb 3;16(2):e0245772. doi: 10.1371/journal.pone.0245772. eCollection 2021. PLoS One. 2021. PMID: 33534813 Free PMC article.
Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City.
Lozano-Cruz OA, Jiménez JV, Olivas-Martinez A, Ortiz-Brizuela E, Cárdenas-Fragoso JL, Azamar-Llamas D, Rodríguez-Rodríguez S, Oseguera-Moguel JC, Dorantes-García J, Barrón-Magdaleno C, Cázares-Diazleal AC, Román-Montes CM, Tamez-Torres KM, Martínez-Guerra BA, Gulias-Herrero A, González-Lara MF, Ponce-de-León-Garduño A, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J. Lozano-Cruz OA, et al. Front Pharmacol. 2021 Jun 3;12:668678. doi: 10.3389/fphar.2021.668678. eCollection 2021. Front Pharmacol. 2021. PMID: 34149420 Free PMC article.
Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center.
Martínez-Guerra BA, de-León-Cividanes NA, Tamez-Torres KM, Román-Montes CM, Rajme-López S, Ortiz-Brizuela E, Aguilar-Salinas CA, Sierra-Madero J, Sifuentes-Osornio J, Ponce-de-León A, González-Lara MF. Martínez-Guerra BA, et al. Rev Invest Clin. 2022 Jan 3;74(1):40-50. doi: 10.24875/RIC.21000404. Rev Invest Clin. 2022. PMID: 34618802 Free article.
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study.
Martinez-Guerra BA, Gonzalez-Lara MF, Roman-Montes CM, Tamez-Torres KM, Dardón-Fierro FE, Rajme-Lopez S, Medrano-Borromeo C, Martínez-Valenzuela A, Ortiz-Brizuela E, Sifuentes-Osornio J, Ponce-de-Leon A. Martinez-Guerra BA, et al. Emerg Microbes Infect. 2022 Dec;11(1):50-59. doi: 10.1080/22221751.2021.2011619. Emerg Microbes Infect. 2022. PMID: 34839785 Free PMC article.
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.
Rajme-López S, Martinez-Guerra BA, Zalapa-Soto J, Román-Montes CM, Tamez-Torres KM, González-Lara MF, Hernandez-Gilosul T, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J, Ponce-de-León A, Ruíz-Palacios GM. Rajme-López S, et al. Open Forum Infect Dis. 2022 Oct 6;9(10):ofac502. doi: 10.1093/ofid/ofac502. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36285176 Free PMC article.
Predictors of Poor Outcomes in Young Non-Comorbid Patients with COVID-19.
Martínez-Guerra BA, Medrano-Borromeo C, González-Lara MF, Román-Montes CM, Tamez-Torres KM, Rajme-López S, Salgado-Guízar KD, Juárez-Menéndez NA, Ramos-Cervantes P, Ruiz-Palacios GM, Ponce-de-León A, Sifuentes-Osornio J. Martínez-Guerra BA, et al. Rev Invest Clin. 2022;74(5):268-275. doi: 10.24875/RIC.22000162. Rev Invest Clin. 2022. PMID: 36328004 Free article.
30 results